[PHARMACOLOGICAL AND THERAPEUTIC STUDIES WITH A NEW QUINAZOLONE DERIVATIVE, NITROMETHAQUALONE].
D000014:Abnormalities, Drug-Induced; D000927:Anticonvulsants; D002415:Cats; D004594:Electrophysiology; D006993:Hypnotics and Sedatives; D008702:Methaqualone / Q000031:analogs & derivatives; D051379:Mice; D009069:Movement Disorders; D009596:Nitrophenols; D010600:Pharmacology; D011807:Quinolizines; D011817:Rabbits; D051381:Rats; D012106:Research; D014116:Toxicology
D000927:Anticonvulsants; D006993:Hypnotics and Sedatives; D009596:Nitrophenols; D011807:Quinolizines; C013153:nitromethaqualone; D008702:Methaqualone
ABNORMALITIES, DRUG-INDUCED; ANTICONVULSANTS; CATS; ELECTROPHYSIOLOGY; EXPERIMENTAL LAB STUDY; HYPNOTICS AND SEDATIVES; MICE; MOVEMENT DISORDERS; PHARMACOLOGY; QUINOLIZINES; RABBITS; RATS; TOXICOLOGIC REPORT
PHARMAKOLOGISCHE UND THERAPEUTISCHE UNTERSUCHUNGEN MIT EINEM NEUEN CHINAZOLONDERIVAT, DEM NITROMETHAQUALON.